Table 5 Clinical data associated with intestinal helminth co-infection among TB patients attending health institutions of Arba Minch town and Arba Minch zuria district from January to August, 2016
Variable | Number examined | Rate of helminth infection (%) | Crude OR (95% CI) | P value | Adjusted OR | P value |
|---|---|---|---|---|---|---|
BMI | ||||||
< 18.5 | 71 | 25 (35.2%) | 2.315 (1.217–4.401) | 0.010 | 3.511 (1.646–7.489) | 0.001 |
≥ 18.5 | 142 | 27 (19.0%) | ||||
Started anti-TB treatment | ||||||
Yes | 200 | 50 (25.0%) | 1.833 (0.393–8.554) | 0.441 | ||
No | 13 | 2 (15.4%) | ||||
Duration of anti-TB treatment | ||||||
1–2 months | 45 | 10 (22.2%) | 1.230 (0.535–2.828) | 0.885 | ||
2–4 months | 55 | 14 (25.5%) | 1.029 (0.484–2.186) | |||
> 4 months | ||||||
Course of treatment | ||||||
First | 190 | 46 (24.2%) | 0.479 (0.130–1.772) | 0.270 | ||
Re-treatment | 10 | 4 (40.0%) | ||||
HIV status | ||||||
Positive | 20 | 3 (15.0%) | 1.929 (0.546–6.871) | 0.110 | ||
Negative | 189 | 48 (25.4%) | ||||